相似文献
1
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.
Cancer Lett. 2009 Jan 8;273(1):107-13. doi: 10.1016/j.canlet.2008.07.031. Epub 2008 Sep 7.
2
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins.
Mol Cancer Ther. 2009 Apr;8(4):904-13. doi: 10.1158/1535-7163.MCT-08-1050.
3
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
J Med Chem. 2010 May 27;53(10):4166-76. doi: 10.1021/jm1001265.
4
Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
Chem Biol. 2004 Mar;11(3):389-95. doi: 10.1016/j.chembiol.2004.02.020.
5
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
J Med Chem. 2010 Nov 25;53(22):8000-11. doi: 10.1021/jm100746q. Epub 2010 Oct 29.
6
Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Oncol Rep. 2013 Aug;30(2):731-8. doi: 10.3892/or.2013.2489. Epub 2013 May 23.
7
A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.
J Med Chem. 2010 Aug 12;53(15):5502-10. doi: 10.1021/jm1001698.
8
Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
Bioorg Chem. 2021 Sep;114:105146. doi: 10.1016/j.bioorg.2021.105146. Epub 2021 Jul 5.
9
Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity.
Bioorg Med Chem. 2005 Jul 1;13(13):4228-37. doi: 10.1016/j.bmc.2005.04.026.
10
Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
Mol Cancer Ther. 2008 Jul;7(7):2192-202. doi: 10.1158/1535-7163.MCT-08-0333.
引用本文的文献
1
Synthetic, Computational, and Experimental Studies of a Class 3 Atropisomeric α-Naphthyl Tropone.
J Org Chem. 2025 Aug 15;90(32):11501-11509. doi: 10.1021/acs.joc.5c00992. Epub 2025 Aug 5.
2
Studies on the Configurational Stability of Tropolone-Ketone-, Ester-, and Aldehyde-Based Chiral Axes.
J Org Chem. 2024 Jan 5;89(1):541-552. doi: 10.1021/acs.joc.3c02286. Epub 2023 Dec 22.
3
Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.
Mol Cancer Ther. 2018 Sep;17(9):1951-1960. doi: 10.1158/1535-7163.MCT-17-1002. Epub 2018 Jun 22.
4
Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo.
Mol Med Rep. 2015 Jun;11(6):4142-8. doi: 10.3892/mmr.2015.3326. Epub 2015 Feb 10.
5
Bcl-2 antagonists: a proof of concept for CLL therapy.
Invest New Drugs. 2013 Oct;31(5):1384-94. doi: 10.1007/s10637-013-0002-4. Epub 2013 Aug 2.
6
Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.
Tetrahedron Lett. 2012 Jan 25;53(4):373-376. doi: 10.1016/j.tetlet.2011.11.065.
7
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Neoplasia. 2012 Jul;14(7):656-65. doi: 10.1593/neo.12640.
8
Synthesis of Hemigossypol and its Derivatives.
Tetrahedron Lett. 2010 Oct 3;51(44):5757-5760. doi: 10.1016/j.tetlet.2010.08.089. Epub 2010 Aug 30.
9
An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins.
Front Oncol. 2011 Sep 30;1:28. doi: 10.3389/fonc.2011.00028. eCollection 2011.
10
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.
J Med Chem. 2010 Nov 25;53(22):8000-11. doi: 10.1021/jm100746q. Epub 2010 Oct 29.
本文引用的文献
1
Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
Blood. 2008 Mar 15;111(6):3211-9. doi: 10.1182/blood-2007-09-113647. Epub 2008 Jan 17.
2
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
J Med Chem. 2006 Oct 19;49(21):6139-42. doi: 10.1021/jm060460o.
3
Quantitative determination of apogossypol, a pro-apoptotic analog of gossypol, in mouse plasma using LC/MS/MS.
J Pharm Biomed Anal. 2006 Nov 16;42(5):581-6. doi: 10.1016/j.jpba.2006.05.020. Epub 2006 Jul 21.
4
Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
Chem Biol. 2004 Mar;11(3):389-95. doi: 10.1016/j.chembiol.2004.02.020.
5
Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.
J Med Chem. 2003 Sep 25;46(20):4259-64. doi: 10.1021/jm030190z.
6
Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells.
Biochem Pharmacol. 2003 Jul 1;66(1):93-103. doi: 10.1016/s0006-2952(03)00248-x.
7
Apoptosis-based therapies.
Nat Rev Drug Discov. 2002 Feb;1(2):111-21. doi: 10.1038/nrd726.
8
Different pathways of cell killing by gossypol enantiomers.
Exp Biol Med (Maywood). 2002 Jun;227(6):398-401. doi: 10.1177/153537020222700605.
9
Apoptosis: a link between cancer genetics and chemotherapy.
Cell. 2002 Jan 25;108(2):153-64. doi: 10.1016/s0092-8674(02)00625-6.
10
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL.
Nat Cell Biol. 2001 Feb;3(2):173-82. doi: 10.1038/35055085.
Zotero 插件